During COVID-19, some patients developed Guillain–Barré syndrome (GBS), an immune-mediated nerve disorder. In this project led by Can Ulutekin we identified a distinct COVID-related immune signature. link.springer.com/article/10.1...

Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome - Journal of Molecular Medicine

Guillain-Barré syndrome (GBS) is an acute immune-mediated neuropathy triggered by infections, with poorly understood pathophysiological diversity. COVID-19-associated GBS (COVID-GBS) is a rare but sev...

link.springer.com

First-Ever Ingelhoeffheimer Retreat: Three Days of Science, breathtaking nature and Fun ✨️ We have just returned from the very first joint Scientific Retreat with the amazing members of the Hoefflin and Wertheimer labs.

hello world. Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies. Follow us for updates on systems immunology, machine learning & translational oncology. fi